So far genetic loss-of-function mutations have been found in patients with leukoencephalopathies with symptoms including ataxia, visual field defects, and learning disabilities10 and azoospermia11, which resembles the phenotype of in Clcn2-deficient mice25,26. This evidence concerns the gene CLCN2 and Leukoencephalopathy.